UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 123

Sortiert nach

Transcription Factor MYB as Therapeutic Target: Current Developments

International journal of molecular sciences, 2024-03, Vol.25 (6), p.3231

Klempnauer, Karl-Heinz

2024

Link zum Volltext

Verfügbarkeit prüfen

Intramolecular interaction of B‐MYB is regulated through Ser‐577 phosphorylation

FEBS letters, 2020-12, Vol.594 (24), p.4266-4279

2020

Link zum Volltext

Verfügbarkeit prüfen

The CDC37‐HSP90 chaperone complex co‐translationally degrades the nascent kinase‐dead mutant of HIPK2

FEBS letters, 2021-06, Vol.595 (11), p.1559-1568

2021

Link zum Volltext

Verfügbarkeit prüfen

Tumor Suppressor Protein Pdcd4 Inhibits Translation of p53 mRNA

The Journal of biological chemistry, 2011-12, Vol.286 (50), p.42855-42862

2011

Link zum Volltext

Verfügbarkeit prüfen

PDCD4 controls the G1/S-phase transition in a telomerase-immortalized epithelial cell line and affects the expression level and translation of multiple mRNAs

Scientific reports, 2020-02, Vol.10 (1), p.2758-2758, Article 2758

2020

Link zum Volltext

Verfügbarkeit prüfen

Characterization of the zinc finger proteins ZMYM2 and ZMYM4 as novel B-MYB binding proteins

Scientific reports, 2020-05, Vol.10 (1), p.8390-8390, Article 8390

2020

Link zum Volltext

Verfügbarkeit prüfen

C/EBPβ is a MYB- and p300-cooperating pro-leukemogenic factor and promising drug target in acute myeloid leukemia

Oncogene, 2021-07, Vol.40 (29), p.4746-4758

2021

Link zum Volltext

Verfügbarkeit prüfen

C/EBPβ sustains the oncogenic program of AML cells by cooperating with MYB and co-activator p300 in a transcriptional module

Experimental hematology, 2022-04, Vol.108, p.8-15

Klempnauer, Karl-Heinz

2022

Link zum Volltext

Verfügbarkeit prüfen

C/EBPβ cooperates with MYB to maintain the oncogenic program of AML cells

Oncotarget, 2023-03, Vol.14 (1), p.174-177

Klempnauer, Karl-Heinz

2023

Link zum Volltext

Verfügbarkeit prüfen

Characterization of the MYB-inhibitory potential of the Pan-HDAC inhibitor LAQ824

BBA advances, 2022-01, Vol.2, p.100034-100034, Article 100034

2022

Link zum Volltext

Verfügbarkeit prüfen

Bcr-TMP, a Novel Nanomolar-Active Compound That Exhibits Both MYB- and Microtubule-Inhibitory Activity

Cancers, 2022-01, Vol.14 (1), p.43

2022

Link zum Volltext

Verfügbarkeit prüfen

A novel cell-based screening assay for small-molecule MYB inhibitors identifies podophyllotoxins teniposide and etoposide as inhibitors of MYB activity

Scientific reports, 2018-09, Vol.8 (1), p.13159-11, Article 13159

2018

Link zum Volltext

Verfügbarkeit prüfen

Transformation suppressor protein Pdcd4 interferes with JNK-mediated phosphorylation of c-Jun and recruitment of the coactivator p300 by c-Jun

Oncogene, 2004-09, Vol.23 (45), p.7484-7493

2004

Link zum Volltext

Verfügbarkeit prüfen

Activation of the oncogenic transcription factor B-Myb via multisite phosphorylation and prolyl cis/trans isomerization

Nucleic acids research, 2019-01, Vol.47 (1), p.103

2019

Link zum Volltext

Verfügbarkeit prüfen

Natural Products with Antitumor Potential Targeting the MYB-C/EBPβ-p300 Transcription Module

Molecules (Basel, Switzerland), 2022-03, Vol.27 (7), p.2077

2022

Link zum Volltext

Verfügbarkeit prüfen

Targeting the transcription factor Myb by small-molecule inhibitors

Experimental hematology, 2017-03, Vol.47, p.31-35

2017

Link zum Volltext

Verfügbarkeit prüfen

Naphthol AS-E Phosphate Inhibits the Activity of the Transcription Factor Myb by Blocking the Interaction with the KIX Domain of the Coactivator p300

Molecular cancer therapeutics, 2015-06, Vol.14 (6), p.1276-1285

2015

Link zum Volltext

Verfügbarkeit prüfen

PRMT4 is a novel coactivator of c-Myb-dependent transcription in haematopoietic cell lines

PLoS genetics, 2013-03, Vol.9 (3), p.e1003343-e1003343

2013

Link zum Volltext

Verfügbarkeit prüfen

Expression of protein kinase HIPK2 is subject to a quality control mechanism that acts during translation and requires its kinase activity to prevent degradation of nascent HIPK2

Biochimica et biophysica acta. Molecular cell research, 2021-01, Vol.1868 (1), p.118894-118894, Article 118894

2021

Link zum Volltext

Verfügbarkeit prüfen

B-Myb promotes S-phase independently of its sequence-specific DNA binding activity and interacts with polymerase delta-interacting protein 1 (Pdip1)

Cell cycle (Georgetown, Tex.), 2012-11, Vol.11 (21), p.4047-4058

2012

Link zum Volltext

Verfügbarkeit prüfen

Helenalin Acetate, a Natural Sesquiterpene Lactone with Anti-inflammatory and Anti-cancer Activity, Disrupts the Cooperation of CCAAT Box/Enhancer-binding Protein β (C/EBPβ) and Co-activator p300

The Journal of biological chemistry, 2016-12, Vol.291 (50), p.26098-26108

2016

Link zum Volltext

Verfügbarkeit prüfen

The transformation suppressor protein Pdcd4 shuttles between nucleus and cytoplasm and binds RNA

Oncogene, 2003-07, Vol.22 (31), p.4905-4910

2003

Link zum Volltext

Verfügbarkeit prüfen

Myb-induced Chromatin Remodeling at a Dual Enhancer/Promoter Element Involves Non-coding RNA Transcription and Is Disrupted by Oncogenic Mutations of v-myb

The Journal of biological chemistry, 2009-12, Vol.284 (51), p.35314-35324

2009

Link zum Volltext

Verfügbarkeit prüfen

The natural anti-tumor compound Celastrol targets a Myb-C/EBP[beta]-p300 transcriptional module implicated in myeloid gene expression.(Research Article)(Transcriptional activator)

PloS one, 2018-02, Vol.13 (2), p.e0190934

2018

Link zum Volltext

Verfügbarkeit prüfen

Recruitment of p300 by C/EBPβ triggers phosphorylation of p300 and modulates coactivator activity

The EMBO journal, 2003-02, Vol.22 (4), p.882-892

2003

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 123

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(118)
Mit Volltextzugriff
(112)

Publikationsform

Artikel
(122)
Buchkapitel
(1)

Sprache

Englisch
(122)
Japanisch
(9)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(89)
Life Sciences & Biomedicine
(80)
Biochemistry & Molecular Biology
(62)
Animals
(60)
Cell Biology
(42)
Humans
(38)
Cell Line
(27)
Chickens
(27)
Molecular Sequence Data
(26)
Binding Sites
(25)
Biological And Medical Sciences
(25)
Gene Expression Regulation
(24)
Oncology
(24)
Fundamental And Applied Biological Sciences. Psychology
(23)
Base Sequence
(22)
Genetics & Heredity
(22)
Transcription Factors
(22)
Molecular And Cellular Biology
(20)
Mice
(19)
Gene Expression
(18)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Transcription Factor MYB as Therapeutic Target: Current Developments

Intramolecular interaction of B‐MYB is regulated through Ser‐577 phosphorylation

The CDC37‐HSP90 chaperone complex co‐translationally degrades the nascent kinase‐dead mutant of HIPK2

Tumor Suppressor Protein Pdcd4 Inhibits Translation of p53 mRNA

PDCD4 controls the G1/S-phase transition in a telomerase-immortalized epithelial cell line and affects the expression level and translation of multiple mRNAs

Characterization of the zinc finger proteins ZMYM2 and ZMYM4 as novel B-MYB binding proteins

C/EBPβ is a MYB- and p300-cooperating pro-leukemogenic factor and promising drug target in acute myeloid leukemia

C/EBPβ sustains the oncogenic program of AML cells by cooperating with MYB and co-activator p300 in a transcriptional module

C/EBPβ cooperates with MYB to maintain the oncogenic program of AML cells

Characterization of the MYB-inhibitory potential of the Pan-HDAC inhibitor LAQ824

Bcr-TMP, a Novel Nanomolar-Active Compound That Exhibits Both MYB- and Microtubule-Inhibitory Activity

A novel cell-based screening assay for small-molecule MYB inhibitors identifies podophyllotoxins teniposide and etoposide as inhibitors of MYB activity

Transformation suppressor protein Pdcd4 interferes with JNK-mediated phosphorylation of c-Jun and recruitment of the coactivator p300 by c-Jun

Activation of the oncogenic transcription factor B-Myb via multisite phosphorylation and prolyl cis/trans isomerization

Natural Products with Antitumor Potential Targeting the MYB-C/EBPβ-p300 Transcription Module

Targeting the transcription factor Myb by small-molecule inhibitors

Naphthol AS-E Phosphate Inhibits the Activity of the Transcription Factor Myb by Blocking the Interaction with the KIX Domain of the Coactivator p300

PRMT4 is a novel coactivator of c-Myb-dependent transcription in haematopoietic cell lines

Expression of protein kinase HIPK2 is subject to a quality control mechanism that acts during translation and requires its kinase activity to prevent degradation of nascent HIPK2

B-Myb promotes S-phase independently of its sequence-specific DNA binding activity and interacts with polymerase delta-interacting protein 1 (Pdip1)

Helenalin Acetate, a Natural Sesquiterpene Lactone with Anti-inflammatory and Anti-cancer Activity, Disrupts the Cooperation of CCAAT Box/Enhancer-binding Protein β (C/EBPβ) and Co-activator p300

The transformation suppressor protein Pdcd4 shuttles between nucleus and cytoplasm and binds RNA

Myb-induced Chromatin Remodeling at a Dual Enhancer/Promoter Element Involves Non-coding RNA Transcription and Is Disrupted by Oncogenic Mutations of v-myb

The natural anti-tumor compound Celastrol targets a Myb-C/EBP[beta]-p300 transcriptional module implicated in myeloid gene expression.(Research Article)(Transcriptional activator)

Recruitment of p300 by C/EBPβ triggers phosphorylation of p300 and modulates coactivator activity

Suchergebnisse filtern